Contact Us

Products
Applications
Technology
Resources
About Us
- Overview
- Management Team
- Board of Directors
- Testimonials
- Careers
- News
- Blog
- Events
- Contact Us
Support
Store

10.18.23

Drug Discovery 2023: An ELRIG Conference

Get the Latest to Your Inbox

First Name(Required)

Last Name(Required)

Email(Required)

CAPTCHA

Latest News

Icosagen Acquires the Carterra LSA Instrument to Significantly Enhance Its Antibody Screening Capabilities in the Discovery and Development of New Therapeutic and Diagnostic Antibodies

Carterra expands best-in-class franchise with the launch of the LSA^XT high-throughput SPR biosensor at SLAS 2023

Ernst and Young Selects Josh Eckman, CEO of Carterra, as 2022 Entrepreneur of the Year Mountain West Award Winner

La Jolla Institute for Immunology Acquires LSA Platform

Carterra Joins the Tetra Partner Network to Advance Therapeutics Discovery

Resources

Webinar

Science Webinar: Advances in HT-SPR, scBCR-seq and RNA-seq

Webinar

Carterra and Aviva 2023 Webinar moderated by DDN

Webinar

Carterra’s Scientist to Scientist Series: Alyssa Hughes and Mike Brown at Adimab

Webinar

Carterra’s Scientist to Scientist Series: Alyssa Hughes and Randi Hansen at Symphogen

Peer-Reviewed Publication

Cell Reports: Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium

825 N. 300 W. Ste. C309
Salt Lake City, UT 84103

Ph: (844) 642-7635
questions@carterra-bio.com

Products
Technology
About Us
News
Events
Resources
Blog
Contact

Applications

Kinetics Software
Epitope Analysis Software for Protein:Protein Interactions
Advanced SPR Platform for High Throughput Kinetics Screening
Epitope Binning
Quantitation
Small Molecule Characterization
Antibody Epitope Mapping
Therapeutic Areas
Antibody Discovery & Other Therapeutic Formats

© 2023 Carterra, Inc. All rights reserved. Unless otherwise noted, Carterra, the Carterra Logo and all other trademarks are property of Carterra, Inc.

Privacy Policy

Website by Metropolis Creative